IMVT R&D Expenses
Immunovant Inc · R&D Expenses
IMVT R&D Expenses
Latest reported$498.09Mperiod ending
IMVT TTM R&D Expenses ($41.73M → $498.09M)
TTM R&D Expenses
High-resolution chart · PNG
IMVT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 498,091,000 | |
| 456,660,000 | |
| 408,024,000 | |
| 403,620,000 | |
| 386,643,000 | |
| 360,916,000 | |
| 333,321,000 | |
| 287,139,000 | |
| 237,826,000 | |
| 212,928,000 | |
| 198,709,000 | |
| 192,623,000 | |
| 182,403,000 | |
| 160,257,000 | |
| 140,406,000 | |
| 127,910,000 | |
| 111,532,000 | |
| 101,808,000 | |
| 88,437,000 | |
| 79,772,000 | |
| 70,387,000 | |
| 68,604,000 | |
| 64,157,000 | |
| 48,019,000 | |
| 46,374,000 | |
| 47,928,000 | |
| 41,729,543 | |
| 44,459,888 | |
| 39,873,769 | |
| 25,733,000 |